H.R. 4752 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Jul 23, 2025
What this bill does
In plain words · AI-written from the official summaryMedicare covers hereditary cancer genetic testing
This bill would expand what Medicare pays for when it comes to hereditary cancer. Specifically, it would cover genetic testing for people who have a personal or family history of hereditary cancer gene mutations, and it would also cover risk-reducing surgeries and screenings related to those mutations.
How it affects you
If you're on Medicare and have a personal or family history of hereditary cancer, this would make it easier and more affordable to get genetic testing to see if you carry a cancer-related gene mutation. You'd also have Medicare coverage for surgeries and screenings recommended to reduce your cancer risk based on those results.
Read the official summary (Introduced in House, Jul 23, 2025)
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionH. R. 4752
A BILL
Reducing Hereditary Cancer Act
Sponsor: Rep. Debbie Wasserman Schultz (D-FL-25) · Introduced Jul 23, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Jul 23, 2025: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”
Sections
Sections · 4
- Sec. 1Short titleNo change
- Sec. 2Hereditary cancer genetic testing of individuals with a family history of a hereditary cancer gene mutation or personal or family history suspicious for hereditary cancerNo change
- Sec. 3Coverage of certain preventive surgeriesNo change
- Sec. 4Coverage of evidence-based screenings for individuals with a hereditary cancer gene mutationNo change